Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review

Wysowski DK, Nourjah P, Swartz L: Bleeding complications with warfarin use. Arch Intern Med 2007, 167: 1414–1419. 10.1001/archinte.167.13.1414

Go AS, Hylek EM, Phillips KA, et al.: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285: 2370–2375. 10.1001/jama.285.18.2370

Jagoda AS, Bazarian JJ, Bruns JJ Jr, et al.: Clinical policy: Neuroimaging and decision making in adult mild traumatic brain injury in the acute setting. Ann Emerg Med 2008, 52: 714–48. 10.1016/j.annemergmed.2008.08.021

Steiner T, Rosand J, Diringer M: Intracerebral hemorrhage associated with oral anticoagulant therapy. Stroke 2006, 37: 256–262.

Thompson KM, Gerlach SY, Jorn KS, et al.: Advances in the care of patients with intracerebral hemorrhage. Mayo Clin Proc 2007, 82: 987–990. 10.4065/82.8.987

Appelboam R, Thomas EO: Warfarin and intracranial haemorrhage. Blood Rev 2009, 23: 1–9. 10.1016/j.blre.2008.05.001

Butler AC, Tait RC: Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev 1998, 12: 35–44. 10.1016/S0268-960X(98)90028-5

Asdaghi N, Manawadu D, Butcher K: Therapeutic management of acute intracerebral haemorrhage. Expert Opin Pharmacother 2007, 8: 3097–3116. 10.1517/14656566.8.18.3097

Beyth RJ: Hemorrhagic Complications of oral anticoagulant therapy. Clin Geriatr Med 2001, 17: 49–56. 10.1016/S0749-0690(05)70105-1

Towfighi A, Greenberg S, Rosand J: Treatment and prevention of primary intracerebral hemorrhage. Semin Neurol 2005, 25: 445–452. 10.1055/s-2005-923538

Freeman WD, Aguilar MI: Management of warfarin-related intracerebral hemorrhage. Expert Rev Neurotherapeutics 2008, 8: 271–290. 10.1586/14737175.8.2.271

Hart RG, Aguilar MI: Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage. J Thromb Thrombolysis 2008, 25: 26–32. 10.1007/s11239-007-0101-1

Hanley JP: Warfarin Reversal. J Clin Pathol 2004, 57: 1132–1139. 10.1136/jcp.2003.008904

Guyatt , et al.: GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011, 64: 380–2. 10.1016/j.jclinepi.2010.09.011

Bartal C, Freedman J, Bowman K, et al.: Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa. J Trauma 2007, 63: 725–732. 10.1097/TA.0b013e318031ccca

Baldi G, Altomonte F, Altomonte M, et al.: Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. Cerebrovasc Dis 2006, 22: 286–293. 10.1159/000094604

Kalina M, Tinkoff G, Gbadebo A, et al.: A protocol for the rapid normalization of inr in trauma patients with intracranial hemorrhage on prescribed warfarin therapy. Am Surg 2008, 74: 858–61.

Ivascu FA, Janczyk RJ, Junn FS, et al.: Treatment of trauma patients with intracranial hemorrhage on preinjury Warfarin. J Trauma 2006, 61: 318–321. 10.1097/01.ta.0000223944.25922.91

Aguilar MI, Hart RG, Kase CS, et al.: Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007, 82: 82–92. 10.4065/82.1.82

Sjoblom L, Hardemark HG, Lindgren A, et al.: Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy (a Swedish multicenter study). Stroke 2001, 32: 2567–2574. 10.1161/hs1101.098523

Goldstein JN, Thomas SH, Frontiero V, et al.: Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 2006, 37: 151–155.

Boulis NM, Bobek MP, Schmaier A, et al.: Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999, 45: 1113–1118. 10.1097/00006123-199911000-00020

Makris M, Greaves M, Phillips WS, et al.: Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Throb Haemostasis 1997, 77: 477–480.

Fredriksson K, Norrving B, Stromblad LG: Emergency reversal of anticoagulation after intracranial hemorrhage. Stroke 1992, 23: 972–977. 10.1161/01.STR.23.7.972

Cartmill M, Dolan G, Byrne JL, et al.: Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000, 14: 458–461. 10.1080/02688690050175265

Siddiq F, Jalil A, McDaniel C, et al.: Effectiveness of factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage. Neurocrit Care 2008, 8: 36–41. 10.1007/s12028-007-9011-5

Fewel ME, Park P: The emerging role of recombinant-activated factor VII in neurocritical care. Neurocrit Care 2004, 1: 19–30. 10.1385/NCC:1:1:19

Levi M, Levy JH, Andersen HF, Truloff D: Safety of recombinant activated factor vii in randomized clinical trials. N Engl J Med 2010, 363: 1791–1800. 10.1056/NEJMoa1006221

Sorensen B, Johansen P, Nielsen G, et al.: Reversal of the international normalized ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003, 14: 469–477. 10.1097/00001721-200307000-00007

Freeman WD, Brott TG, Barrett KM, et al.: Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004, 79: 1495–1500. 10.4065/79.12.1495

Brody DL, Aiyagaria V, Shackleford AM, et al.: Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocritical Care 2005, 2: 263–267. 10.1385/NCC:2:3:263

Nishijima DK, Dager WE, Schrot RJ, et al.: The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage. Acad Emerg Med 2010, 17: 244–251. 10.1111/j.1553-2712.2010.00666.x

Makris M, van Veen JJ, Maclean R: Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient. J Thromb Thrombolysis 2010, 29: 171–81. 10.1007/s11239-009-0412-5

Fiore LD, Scola MA, Cantillon CE, et al.: Anaphylactoid reactions to vitamin K. J Thromb Thrombolysis 2001, 11: 175–183. 10.1023/A:1011237019082

Phan TG, Koh M, Wijdicks EF: Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 2000, 57: 1710–1713. 10.1001/archneur.57.12.1710

Rabinstein AA, Wijdicks EM: Determinants of outcome in anticoagulation-associated cerebral hematoma requiring emergency evacuation. Arch Neurology 2007, 64: 203–206. 10.1001/archneur.64.2.noc60131

Yasaka M, Sakata T, Naritomi H, et al.: Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 2005, 115: 455–459. 10.1016/j.thromres.2004.09.002

Preston FE, Laidlaw ST, Sampson B, et al.: Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002, 116: 619–624. 10.1046/j.0007-1048.2001.03295.x

Nitu IC, Perry DJ, Lee CA: Clinical experiences with the use of clotting factor concentrates in oral anticoagulation reversal. Clin Lab Haem 1998, 20: 363–367. 10.1046/j.1365-2257.1998.00161.x

Lee SB, Manno EM, Layton KF, et al.: Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology 2006, 67: 1272–1274. 10.1212/01.wnl.0000238104.75563.2f

Berwaerts J, Robb OJ, Dykhuizen RS, et al.: Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages. Scott Med J 2000, 45: 105–109.

Huttner HB, Schellinger PD, Hartmann M, et al.: Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy. Stroke 2006, 37: 1465–1470. 10.1161/01.STR.0000221786.81354.d6

Yasaka M, Sakata T, Minematsu K, et al.: Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res 2003, 108: 25–30.